RxDoctor Payments Data

Janine Hyden

Acute Care · Houston, TXNPI 1982700464

Payments from drug & device makers

$2,711in general payments, 2019–2025

Across 143 payments — averaging $18.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$808
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$648
  • AstraZeneca$228
  • Madrigal Pharmaceuticals$155
  • Astellas Pharma US Inc$106
  • Sanofi-aventis U.S. LLC$105
  • plus $663 from 12 others

What the payments were for

  • Food & beverage$2,64998%
  • Education$622%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,711 in reported general payments places this provider in the 85th percentile of 2,323 acute care providers in Texas.

See all acute care providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omega-3 Acid Ethyl Esters15$313
Atorvastatin Calcium17$93

Paid to pharmacies, not to this prescriber.

Other acute care in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →